Clinical evaluation of the Dr. Brain syrup in the treatment of anxiety, depression, and dementia: randomized, placebo controlled, single blinded clinical study

Hardik R. Patel, Kalapi Patel, Mansi Patel, S. N. Gupta, Janmejay Patel, Payal Patel, Apurva Patel

Abstract

Background: Epidemiological studies of Indian population show that dementia, anxiety, and depression are largely a major hidden problem in India. Ayurveda claims several plants are beneficial in cognitive disorders. The prime objective of study was to clinically evaluate polyherbal formulation (Dr. Brain syrup) and compare it with the Placebo. It was randomized, placebo controlled, single blinded clinical study, approved by Institutional Human Ethics Committee.

Methods: 60 outpatients from P. D. Patel Ayurveda Hospital (8-70 years) ready to sign Informed consent form were included in study. All these patients were given either Placebo syrup or Dr. Brain syrup at similar dose of 10 ml twice a day for 6 weeks. They were evaluated based on the HADS (hospital anxiety depression scale), EDQ (early dementia questionnaire) and symptoms assessment parameters on weekly basis.

Results: Result showed that there was significant reduction in HADS score at the end of the study. Moreover, the sensitivity and specificity of the HADS was observed highly relevant to detect the level of anxiety and depression by obtaining ROC curve. Numerical analysis of the EDQ was also shown eye-catching differences in patient receiving Dr. Brain syrup improved their memory at the end of the study compared to placebo group.  

Conclusions: This study prooves the efficacy and safety of the Dr. Brain syrup in improving the memory and reducing the level of anxiety and depression in particular diseased patients without any side effects.

 

Keywords

Anxiety, Depression, HADS, EDQ, Memory enhancement

Full Text:

PDF

References

Parle M, Vasudevan M. Memory Enhancing Activity of Abana: An Indian Ayurvedic Poly-Herbal Formulation. J Health Sci. 2007;53(1):43-52.

Ladde S, Gouda ST, Rao NV, Shalam, Verma R. Evaluation of nootropic activity of polyherbal formulation SR-105 in experimental animals. Int Res J pharmacy. 2011;2(4):101-7.

Katare YS, Bhujbal SS, Bafna AR, Shyale SS. Evaluation of anxiolytic effect of a polyherbal formulation in mice. Euro J Exp Bio. 2012;2(6):2093-8.

Jyothi CH, Santhosh R, Gokul CG, Kiran LJ, Narendranath S, Abhishek Acharya A, et al. A study on anxiolytic effect of Flupirtine in albino rats. J Pharmacy Res. 2012;5(3):1624-7.

Shah J, Goyal R. Comparative clinical evaluation of herbal formulation with multivitamin formulation for learning and memory enhancement. Asian J Pharma Clin Res. 2010;3(1):69-75.

Al-Snafi AE. The pharmacology of Bacopa monniera. Areview. Int J Pharma Sci Res. 2013;4(12):154-9.

Singh HK, Dhawan BN. Neuropsycho-pharmacological effects of the ayurvedic nootropic Bacopa monnieri Linn. (Brahmi). Indian J Pharmacol. 1997;29:359-65.

Debjit B, Kumar KPS, Paswan S, Srivatava S, Yadav AP, Dutta A. Traditional Indian Herbs Convolvulus pluricaulis and Its Medicinal Importance. Phytojournal. 2012;1(1):44-51.

Agrawal M, Tyagi T. Therapeutic efficacy of Centella asiatica (L.) and Momordica charantia: As traditional medicinal plant. J Plant Sci. 2015;3(1-1):1-9.

Upadhyay SK, Bhatia BD, Kulkarni KS. Evaluation of the Efficacy of Mentat in Children with Learning Disability: A Placebo-Controlled Double-Blind Clinical Trial. Neuroscience today. 2002;6(3):184-8.

Tilaki KH. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med. 2013;4(2):627-35.

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosomatic Res. 2002;52:69-77.

Bhaskaran M, Sengottainyan A, Madhu S, Ranganathan V. Evaluation of memory in abacus learners. Indian J Physiol Pharmacol. 2006;50(3):225-33.